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Human embryonic stem cells (hESCs) and induced
pluripotent stem cells (hiPSCs) have been shown to
differentiate into primordial germ cells (PGCs) but
not into spermatogonia, haploid spermatocytes, or
spermatids. Here, we show that hESCs and hiPSCs
differentiate directly into advanced male germ cell
lineages, including postmeiotic, spermatid-like cells,
in vitro without genetic manipulation. Furthermore,
our procedure mirrors spermatogenesis in vivo by
differentiating PSCs into UTF1-, PLZF-, and CDH1-
positive spermatogonia-like cells; HIWI- and HILI-
positive spermatocyte-like cells; and haploid cells
expressing acrosin, transition protein 1, and prot-
amine 1 (proteins that are uniquely found in sperma-
tids and/or sperm). These spermatids show unipa-
rental genomic imprints similar to those of human
sperm on two loci: H19 and IGF2. These results
demonstrate thatmale PSCs have the ability to differ-
entiate directly into advanced germ cell lineages and
may represent a novel strategy for studying sper-
matogenesis in vitro.
INTRODUCTION
Infertility affects15% of couples, with male factors responsible
for 40%–60% of cases of infertility (Schlegel, 2009). For men
without a genetic cause of infertility, stem cell transplantation
represents a possible treatment option (Marques-Mari et al.,
2009; Mathews et al., 2009; Yao et al., 2011). Protocols to
preserve future fertility in boys who are undergoing cancer ther-
apies and cannot yet bank their own sperm are under develop-
ment (Hermann et al., 2007; Sadri-Ardekani et al., 2011; Schlatt
et al., 2009). However, for adult and prepubescent patients who
have been rendered sterile prior to sperm collection, no treat-
ments to restore fertility are currently available.440 Cell Reports 2, 440–446, September 27, 2012 ª2012 The AuthorMouse embryonic stem cells (ESCs) (Geijsen et al., 2004; Hay-
ashi et al., 2011), nonhuman primate (NHP) ESCs, and human
ESCs (hESCs) (Bucay et al., 2009; Fukunaga et al., 2010; Kee
et al., 2009; Panula et al., 2011; Park et al., 2009; Teramura
et al., 2007; Tilgner et al., 2008; Yamauchi et al., 2009) have
been differentiated into primordial germ cells (PGCs), fetal pre-
cursors of the spermatogenic lineage. In addition, recent studies
suggest that human pluripotent stem cells (hPSCs) can enter
meiosis and in some cases produce haploid products (Eguizabal
et al., 2011; Kee et al., 2009; Panula et al., 2011). In this study,
we developed an in vitro method that achieves two significant
endpoints. First, male hESCs and human induced PSCs (hiPSCs)
differentiate directly into adult-type spermatogonia. Second, dif-
ferentiating stem cells give rise to cells that are phenotypically
similar to postmeiotic round spermatids. These results highlight
the full plasticity of hPSCs by showing their ability to undergo
spermatogenesis in vitro, culminating with haploid round sper-
matid-like cells. These results also contribute to the overall
goal of both understanding germ cell development in vitro and
ultimately generating gametes that may prove invaluable for un-
derstanding infertility mechanisms.
RESULTS
Mouse Spermatogonial Stem Cell Conditions Elevate
the Expression of Germ Cell Markers
Previous studies have shown that human testis cells cultured
in PSC conditions directly dedifferentiate into PSCs (Conrad
et al., 2008; Ko et al., 2009; Kossack et al., 2009). Thus, we
examined whether ESCs could directly differentiate into germ-
line stem cells. Our goal was to differentiate PSCs into spermato-
gonial stem cell (SSC)-like cells, because this spermatogenic
lineage has shown an exceptional ability to recolonize sterilized
testes and thus restore fertility in certain species, including
mice and NHPs (Brinster and Avarbock, 1994; Jahnukainen
et al., 2011). One advantage of this strategy is that there are es-
tablished protocols for culturing and expanding rodent SSCs
in vitro (Kanatsu-Shinohara et al., 2003). We cultured H1 (WA01)
hESCs and human foreskin fibroblast 1 (HFF1) iPSCs directly ins
Figure 1. Differentiation of hPSCs in SSC
Culture Yields Significant Percentages of
VASA+ Cells
(A) H1 ESCs and HFF-1 iPSCs cultured in mouse
SSC conditions for 10 days and then stained for
VASA. The percentage of VASA expression was
quantified in the parent PSC lines and the differ-
entiated lines. A representative graphical analysis
from five separate trials, with >5,000 cells counted
for each condition, is shown. *p < 0.01 comparing
H1 ESC with H1 SSC; #p < 0.01 comparing HFF1
iPSC with HFF1 SSC. Error bars shown for each
data set represent the standard deviation (SD) of
the mean.
(B) Representative images of PSCs and PSCs
differentiated in SSC culture conditions for 10 days
and stained for VASA. DNA labeled with Hoechst.
Scale: 50 mm. Enlarged insets show typical peri-
nuclear localization of VASA.
(C) RT-PCR for germ cell markers DAZL, VASA,
CXCR4, and PIWIL1 in PSCs and their differenti-
ated counterparts. Glyceraldehyde 3-phosphate
dehydrogenase (GADPH) is shown as a loading
control. No DNA (DNA) is also shown as a nega-
tive control.
(D) Representative western blot analyses showing
upregulation of germ cell marker expression and
a concomitant loss of the pluripotent marker
Nanog in complete SSC culture conditions (with
GDNF and FGF). Despite loss of Nanog in FGF-
only SSC medium (i.e., without GDNF), germ cell
markers were not expressed. Actin is a loading
control.standardized mouse SSC culture conditions. After a 10 day
culture, we observed significant increases in VASA+ cells, with
60% of H1 cells and 40% of HFF1 cells expressing VASA
(Figures 1A and 1B and enlarged insets). These VASA+, germ-
like cells showed typical VASA staining patterns as seen in
human testis sections (Figure S1A). Day 10 was the optimum
time point, because day 7 cultures yielded lower numbers of
VASA+ cells and day 15 cultures did not yield an appreciable
increase (Figure S1B). In comparison with previous protocols,
we observed a 4- to 5-fold increase in VASA+ cells derived
from hPSCs, all within 10 days postdifferentiation.
We further analyzed H1 and HFF1 cells cultured in mouse SSC
conditions (termed H1 SSC and HFF1 SSC, respectively) for
expression of additional germ cell markers. Deleted-in-Azoo-
spermia-like (DAZL) and VASA are two germline-specific, RNA-
binding proteins that are important in germ cell development
and normal spermatogenesis (Castrillon et al., 2000; Kee et al.,
2009). Recently, Kee et al. (2009) showed that some hESCs,
mainly female lines, express low levels of VASA mRNA. Here,
both male hESC and hiPSC lines did not exhibit expression of
VASA mRNA (Figure 1C). H1 SSC and HFF1 SSC cells showed
an increase in all germ cell markers tested, including CXCR4Cell Reports 2, 440–446, Seand PIWIL1, by reverse transcriptase
(RT)-PCR, suggesting that this is an effi-
cient way to generate germ cell lineages
(Figure 1C). VASA and DAZL protein ex-pression was also elevated in H1 SSCs and HFF1 SSCs com-
pared with the undifferentiated, parent PSC lines (Figure 1D).
We also observed that germ cell differentiation was dependent
on the growth factor glial-derived neurotrophic factor (GDNF;
hPSCs + Complete). Cells differentiated without GDNF (hPSCs +
fibroblast growth factor [FGF] only) demonstrated no increase in
VASA or DAZL protein expression but did show a loss of the
pluripotent marker Nanog, suggesting that both H1 hESCs and
HFF1 hiPSCs differentiated (Figure 1D). These results suggest
that GDNF containing SSC medium efficiently and rapidly differ-
entiates hPSCs into germ cell lineages.
hPSCs Cultured in Mouse SSC Conditions Express PLZF
CXCR4 is a chemokine receptor that is expressed by spermato-
gonia and plays a role in SSC maintenance (Payne et al., 2010).
Because we detected elevations in CXCR4 in both H1 SSCs and
HFF1 SSCs (Figure 1C), we next evaluatedwhether H1SSCs and
HFF1 SSCs expressed PLZF, a zinc-finger transcription factor
that is a consensus marker of stem and progenitor spermato-
gonia. PLZF, or ZBTB16, plays a critical role in SSC self-renewal
and growth (Buaas et al., 2004; Costoya et al., 2004; Hobbs
et al., 2010). A 10 day culture in mouse SSC conditions inducedptember 27, 2012 ª2012 The Authors 441
Figure 2. Differentiation of hPSCs in SSC Conditions Results in
Expression of the SSC Marker PLZF
Although the parent PSC lines do not express detectable levels of
PLZF, 10 day culture in SSC conditions upregulates PLZF (red) expression in
both lines. Hoechst (blue): DNA. Scale: 40 mm. Global view (rows 3 and 6)
of differentiated colonies shows a large portion of cells expressing PLZF.
Scale: 100 mm. The row 7 panel depicts PLZF staining in human testis
sections.expression of PLZF, localized to the nucleus, in both H1 and
HFF1 SSCs (Figure 2). This nuclear expression of PLZF mirrors
that observed in human testes (Figure 2, row 7). Furthermore,
our protocol generates a high percentage of PLZF-positive
cells within differentiating colonies (Figure 2, low-magnification
views, rows 3 and 6), with 82% of H1 SSCs and 78% HFF1
SSCs expressing PLZF (Figure S2A). Unlike other methods, our
protocol induces PLZF expression (Figure S2B). This suggests
that we are more closely mirroring the early events of in vivo
spermatogenesis.
SSC Conditions Yield Postmeiotic, Acrosin-Positive
Cells
SSCs are defined in part by their ability to produce gametes
through a complex combination of division and differentiation.442 Cell Reports 2, 440–446, September 27, 2012 ª2012 The AuthorMouse SSCs can differentiate into haploid cells in vitro (Feng
et al., 2002), so we next quantified whether haploid cells
were produced in H1 SSCs and HFF1 SSCs. Flow cytometry
analyses indicated that a haploid population exists in H1
SSCs (4.5%) and HFF1 SSCs (3.9%) corresponding to
haploid peaks observed with human sperm (Figure 3A; Fig-
ure S3A). We further confirmed haploidy of isolated cells by
fluorescence in situ hybridization (FISH) with a locked nucleic
acid (LNA) probe to satellite DNA found on chromosomes 1,
9, 16, and Y (Figure S3C). After fluorescence-activated cell
sorting (FACS), the majority of haploid cells isolated from
both H1 SSCs and HFF1 SSCs exhibited polar acrosin localiza-
tion (Figure 3B, enlarged insets; Figure S3B). These results
suggest that we are able to generate a small percentage
of acrosin-positive, haploid cells in vitro from hPSCs within
10 days of SSC culture. Ten days proved to be optimal
because haploid cell production decreased after 20 days
(Figure S3D).
hPSC Differentiation in SSC Conditions Generates Cells
that Express Markers for Spermatogonia, Premeiotic
Spermatocytes, Postmeiotic Spermatocytes, and Round
Spermatids
Because differentiation in SSC conditions altered cell-cycle
profiles (Figures S4A and S4B) and yielded a small percentage
of haploid cells in addition to a large population of PLZF-positive
spermatogonia, we next evaluated whether H1 ESCs and HFF1
iPSCs differentiated into intermediate cell types observed in
in vivo spermatogenesis. In addition to PLZF, we observed
expression of UTF1 and CDH1 (Figure 4A, left column), proteins
that are expressed in both spermatogonia and PSCs. In contrast
to the PSCs, we observed an increase in protein expression of
RET and GFRa1 (Figure 4A, western blots), receptors for GDNF
that are found on spermatogonia.
Differentiation of hPSCs in SSC conditions showed an in-
crease in PIWIL1 RNA expression (Figure 1C). PIWIL1 (also
known as HIWI) is essential in spermatogenic progression from
SSCs to round spermatids (Deng and Lin, 2002). We examined
the expression of three spermatocyte markers for premeiotic
spermatocytes/differentiating spermatogonia, meiotic sper-
matocytes, and postmeiotic spermatocytes. We identified cells
in both differentiating H1 ESCs and HFF1 iPSCs expressing
premeiotic HILI protein, the meiotic marker synaptonemal com-
plex 3 (SYCP3, which is involved in recombination and segrega-
tion of meiotic chromosomes), and postmeiotic HIWI (Figure 4A,
center column). Although therewere a large number of HILI-posi-
tive cells, very few cells expressed SYCP3 or HIWI, suggesting
that there is bottleneck prior to meiosis.
We next isolated cells from the haploid peaks by FACS and
immunostained these cells for spermatid markers. During sper-
miogenesis, acrosin expression is turned on and histones are re-
placed by protamines via transition proteins (Carrell et al., 2007).
Haploid cells isolated from H1 and HFF1 SSC cultures express
the postmeiotic sperm markers acrosin, protamine 1 (Prot1),
and transition protein 1 (TP1; Figure 4, right column). In partic-
ular, acrosin staining exhibits polar localization in both cell lines
(Figure 4A, row 1). These haploid cells resemble round sperma-
tids by acrosin localization, the nuclear/perinuclear localizations
Figure 3. hPSCs Differentiated in SSC
Culture Exhibit Haploid Features
(A) FACS ploidy analysis reveals a small haploid
peak in hPSCs cultured in SSC culture conditions
for 10 days. This peak corresponds to the haploid
peak observed in human sperm. The chart below
represents the percentage of haploid cells in
undifferentiated and SSC-mediated differentiated
hPSCs. Data are representative of five cell sorts,
with 500,000 cells sorted per experiment.
(B) FACS-isolated haploid cells from H1 SSC (left)
and HFF1 SSC (right) were seeded on coverslips
and stained with acrosin (red) and Hoechst (DNA,
blue). Global view shows several isolated cells with
polar acrosin localization. Scale: 50 mm. Insets
show zoomed view of acrosin-positive haploid
cells.of TP1, and the perinuclear localization of Prot1 (Figure 4A, right
column), which localizes to the perinuclear region of haploid cells
and enters the nucleus at the elongated spermatid stage (Carrell
et al., 2007). All acrosin-positive cells were also positive for TP1
(Figure S4C). These haploid cells also resemble round sperma-
tids observed in humans and NHPs (Carrell et al., 2007; Moreno
et al., 2006; Ramalho-Santos et al., 2002; also see Figure S4D).
These results coupled with the above PIWIL1 expression data
suggest that PSCs are able to differentiate directly into postmei-
otic, round, spermatid-like cells in vitro.
During in vivo germ cell specification, genomic imprints are
removed at the primordial germ cell stage and then reestab-
lished during spermatogenesis (Lucifero et al., 2002). In mice,
differentiation of PSCs into functional germ cells results in
progeny that exhibit epigenetic disease phenotypes (Nayernia
et al., 2006; Nolte et al., 2010). It was proposed that this may
be due to improper imprinting during gametogenesis (Lucifero
and Reik, 2006). To evaluate imprinting statuses on the haploid
spermatids differentiated here, we isolated haploid cells byCell Reports 2, 440–446, SeFACS and examined the methylation
status of the imprinting control region
(ICR) for paternally imprinted (H19) and
maternally imprinted (IGF2) genes. As
previously reported, iPSCs showed aber-
rant imprinting (Pick et al., 2009), but
ESCs showed typical somatic cell
imprinting on ICRs for H19 and IGF2
(Figure 4B). Isolation of haploid cells
from H1 SSC cultures showed imprint-
ing patterns similar to those observed in
human sperm, with H19 ICR methylation
of 90% and IGF2 ICR methylation of
5% (Figure 4B). Haploid cells from
HFF1 SSCs showed levels of H19 ICR
methylation similar to those observed
in human sperm (90%), but IGF2 meth-
ylation (14%) was slightly elevated
above that observed in human sperm
(Figure 4B). These results suggest that
the haploid products obtained show simi-lar DNA methylation patterns on at least two parent-of-origin
genomic imprints.
DISCUSSION
Several studies have shown that hPSCs differentiate in vitro and
in vivo into the three germ layers (endoderm, mesoderm, and
ectoderm). However, only recently have studies shown that
hPSCs exhibit greater plasticity by differentiating into germ cell
lineages. Our study shows that male diploid PSCs differentiate
into advanced haploid lineages, including round spermatids.
Although female PSCs do not differentiate and undergo cell
death in our protocol (data not shown), methods have been
developed to generate haploid oocyte-like cells from female
lines (for review, see Virant-Klun et al., 2011), furthering demon-
strating that bothmale and female PSCs possess the potential to
differentiate into any adult cell type, including gametes.
The generation of viable sperm and spermatids in vitro from
PSCs and even somatic cells in humans and other primatesptember 27, 2012 ª2012 The Authors 443
Figure 4. Differentiation of hPSCs in SSC
Culture Yields Cells that Express Markers
for Spermatogonia, Spermatocytes, and
Spermatids
(A) Left: 10 days postdifferentiation, cultures of H1
and HFF1 SSCs express the premeiotic sper-
matogonial markers UTF1 and CDH1. Scale:
50 mm. Differentiation also induces expression of
two membrane receptors, RET and GFRa1. Actin
is a loading control. Center: Expression of sper-
matogonia-to-spermatocyte marker HILI, sper-
matocyte-to-spermatid marker HIWI, and meiotic
marker SYCP3. Scale for HILI: 200 mm; scale for
HIWI: 500 mm; and scale for SYCP3: 10 mm. Right:
Expression of the postmeiotic spermatid markers
acrosin, Prot1, and TP1. Haploid cells were sorted
by FACS and immunostained with antibodies
directed at the indicated protein. Scale: 10 mm.
(B) H1 ESCs, HFF1 iPSCs, fertile human sperm,
and haploid cells obtained by FACS from H1 and
HFF1 SSC cultures were examined for methylation
on ICRs for H19 (paternally imprinted) and IGF2
(maternally imprinted). Methylation status was
examined using the QIAGEN Epitect Methyl II PCR
Array. The graph shows the average percentage
of methylation with error bars. Error bars shown
represent the SD of the mean for each data set.has many biomedical justifications even though the endeavor
is fraught with experimental and bioethical challenges (Daley,
2007). Furthermore, the stringency with which these in vitro
sperm are evaluated varies according the necessary endpoint.
The greatest stringency is required for the generation of fully
functional sperm or spermatids that would be considered useful
and safe for fertilization in assisted reproductive technology
(ART) clinics. This objective is justified by the Oncofertility Con-
sortium, which pursues the benevolent goal of preserving fertility
in male cancer survivors who have been rendered infertile during
their therapies but are also too young or fragile to produce a
sperm specimen for cryobanking (Woodruff, 2010). It is also
supported by ART practitioners for the potential treatment of
men with either diagnosed or idiopathic infertility who cannot
provide either sperm or elongated spermatids. Discovering the
stages during spermatogenesis at which various forms of idio-
pathic male infertility arrest would greatly aid in the diagnosis
of (and perhaps the development of treatments for) these still
mysterious processes. Knowledge about these spermatogenic
arrest sites might also contribute to the design of novel contra-
ceptives. In addition, the epigenetic modifications that enable
the properly imprinted sperm chromatin and the replacement
of nuclear proteins to form the sperm nucleus could be better
investigated in these types of cell cultures versus in intact
tissues, especially since our protocol seems to generate haploid
products with parent-of-origin imprints similar to those observed
in fertile human sperm. Anticipated improvements in the effi-
ciency of in vitro spermatogenesis may also help elucidate
how mitochondria are modified to create the sperm mitochon-
dria, and how the somatic centrosome is reduced during male
meiosis to form the sperm tail’s basal body and the sperm
centrosome (Schatten, 1994).444 Cell Reports 2, 440–446, September 27, 2012 ª2012 The AuthorDifferentiating hPSCs into SSCs is an important step in
evaluating the possibility of transplanting patient-specific PSCs
or SSCs to restore fertility. The ability to differentiate hPSCs
directly into SSCs without having to go through a PGC differen-
tiation protocol is likewise important for decreasing differentia-
tion strategy time frames to increase utilization within a clinical
setting. Furthermore, differentiation in SSC conditions yielded
several cell types that are observed during spermatogenesis,
suggesting that ultimately, patient-specific spermatogenesis
can be studied in vitro with only PSCs. We observed the expres-
sion of putative markers for spermatogenesis, including markers
for undifferentiated spermatogonia, differentiating spermato-
gonia, premeiotic spermatocytes, meiotic and postmeiotic sper-
matocytes, and spermatids. In contrast to published results
(Bucay et al., 2009; Fukunaga et al., 2010; Kee et al., 2009; Pan-
ula et al., 2011; Park et al., 2009; Teramura et al., 2007; Tilgner
et al., 2008; Yamauchi et al., 2009), our study not only outlines
an approach for generating large numbers of VASA+ cells but
also describes a method for rapidly and directly differentiating
hPSCs into advanced germ cell lineages, including round sper-
matids, using only extrinsic factors with no genetic manipulation.
Thus, the differentiation method presented here may contribute
to the overall objective of using patient-specific hiPSCs to
generate germ cell lineages capable of restoring fertility in sterile
male patients.
Complete spermatogenesis in vitro has not yet been accom-
plished in humans. Because this strategy attempts to mimic
in vivo spermatogenesis by generating undifferentiated sper-
matogonia as well as haploid round spermatids, it provides
evidence that studying spermatogenesis through the round
spermatid stage in vitro is feasible; however, additional work is
needed to confirm that an individual cell progresses through alls
premeiotic, meiotic, and postmeiotic stages. Although tech-
niques for using round spermatids to fertilize oocytes have not
been proven in humans and NHPs, this protocol may allow
researchers to study cytoplasmic events during early spermato-
genesis from hPSCs to SSCs, as well as to characterize events
associated with spermiogenesis to the round spermatid stage.
Our differentiation scheme may also represent a tool for
exploring the root causes of male factor infertility. By deriving
hiPSCs from infertile men, such as patients with Sertoli-cell-
only (SCO) syndrome, followed by direct differentiation with
our protocol, we could examine where spermatogenesis arrests,
and in the case of SCO patients, identify whether hiPSCs can
differentiate into SSCs and whether viability of SSCs is a major
concern. Advances such as these would undoubtedly shed
new light on the root causes of male factor infertility and clarify
whether multiple disorders contribute to a patient’s infertility.
These potential clinical applications thus underscore the impor-
tance of improving our differentiation protocol to increase the
efficiency of haploid cell generation as well as progressing fur-
ther through spermiogenesis. It will be important to evaluate pre-
clinically whether these in-vitro-generated gamete precursors
have reproductive capabilities in vivo that will be helpful for infer-
tility patients; however, these cells will be of keen biological
importance regardless.
EXPERIMENTAL PROCEDURES
Mouse SSC Differentiation Medium and FACS
H1 (WA01, WiCell) hESCs and HFF1 (parent fibroblasts from ATCC, iPS
derived internally) (Easley et al., 2012) hiPSCs were cultured for 10 days in
mouse SSC medium containing (all from Sigma, unless otherwise noted)
minimum essential medium (MEM) alpha (Invitrogen), 0.2% bovine serum
albumin, 5 mg/ml insulin, 10 mg/ml transferrin, 60 mMputrescine, 2 mM L-gluta-
mine (Invitrogen), 50 mM b-mercaptoethanol, 1 ng/ml human basic FGF
(hbFGF; BD Biosciences), 20 ng/ml GDNF (R&D Systems), 30 nM sodium sele-
nite, 2.36 mM palmitic acid, 0.21 mM palmitoleic acid, 0.88 mM stearic acid,
1.02 mM oleic acid, 2.71 mM linoleic acid, 0.43 mM linolenic acid, 10 mM
HEPES, and 0.5X penicillin/streptomycin (Invitrogen). To isolate haploid cells
by FACS, H1 SSCs and HFF1 SSCs were stained with Vybrant DyeCycle Violet
live-cell stain (Invitrogen) in the SSCmedium described above but substituting
OptiMeM with no phenol red and run on a FACS Aria sorter (BD Biosciences).
Haploid cells were then cultured on poly-D-lysine-coated coverslips and fixed
with 4% paraformaldehyde prior to immunostaining.
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